Prevalence of treatment-resistant hypertension after considering pseudo-resistance and morbidity: a cross-sectional study in Irish primary care

What is it about?

Apparent treatment-resistant hypertension (aTRH) appears common in clinical practice. However, this paper demonstrates that most cases of aTRH may be due to "pseudo-resistance" (i.e., inadequate dosing of anti-hypertensive drugs, white-coat hypertension, and/or poor adherence).

Featured Image

Why is it important?

Patients with aTRH who are pseudo-resistant are at risk of increased morbidity and unnecessary intensification of treatment. Consideration of dosing, white-coat effects, and adherence may be all that is required for hypertension management in the majority of cases.